Cargando…
Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers
BACKGROUND: The relationship between molecular heterogeneity and clinical features of pancreatic cancer remains unclear. In this study, pancreatic cancer was divided into different subgroups to explore its specific molecular characteristics and potential therapeutic targets. PATIENTS AND METHODS: Ex...
Autores principales: | Zhang, Heying, Zeng, Juan, Tan, Yongqiang, Lu, Lin, Sun, Cheng, Liang, Yusi, Zou, Huawei, Yang, Xianghong, Tan, Yonggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140745/ https://www.ncbi.nlm.nih.gov/pubmed/30254473 http://dx.doi.org/10.2147/OTT.S163139 |
Ejemplares similares
-
Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells
por: Zeng, Juan, et al.
Publicado: (2018) -
Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer
por: Tan, Yonggang, et al.
Publicado: (2015) -
Transcription levels and prognostic significance of the NFI family members in human cancers
por: Li, Yuexian, et al.
Publicado: (2020) -
m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
por: Zeng, Juan, et al.
Publicado: (2021) -
Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining
por: Zeng, Juan, et al.
Publicado: (2021)